united-animal-health Research by SuperAGI

United Animal Health Company Profile

Background

United Animal Health, established in 1956 by John B. Swisher, is a privately held company headquartered in Sheridan, Indiana. The company specializes in providing research-based nutrition and health solutions to livestock producers, aiming to enhance animal performance and producer profitability. With nearly 70 years of experience, United Animal Health has expanded its operations to over 20 countries, including markets in Asia and the Americas, supporting swine, poultry, and dairy operations.

Key Strategic Focus

United Animal Health's strategic focus centers on developing science-driven technologies that improve animal health, efficiency, and resilience in modern livestock production systems. The company emphasizes:

Core Objectives: Enhancing animal performance and producer profitability through innovative nutrition and health solutions.

Areas of Specialization: Swine, dairy, and poultry nutrition and health products.

Key Technologies Utilized: Microbial research, pathogen insight, biological innovation, and field-validated research.

Primary Markets Targeted: Livestock producers across North America, Asia, and the Americas.

Financials and Funding

United Animal Health has raised a total of $1.48 million across 13 funding rounds, with the most recent being an unspecified round of $50,601 completed in September 2015. The primary investor is the United States Department of Agriculture. The capital raised has been utilized to support the company's research and development initiatives, expand its product offerings, and enhance its global presence.

Pipeline Development

United Animal Health's pipeline includes a range of products designed to improve animal health and production efficiency. While specific pipeline candidates and clinical trial stages are not publicly disclosed, the company's focus remains on developing solutions that address real-world challenges in livestock production.

Technological Platform and Innovation

United Animal Health distinguishes itself through several technological platforms and innovations:

Proprietary Technologies: Development of microbial-based nutrition products and enzyme products tailored for the animal nutrition industry.

Significant Scientific Methods: Integration of microbial research, pathogen insight, and biological innovation into practical production systems.

AI-Driven Capabilities: While specific AI-driven capabilities are not detailed, the company's commitment to scientific discovery and applied research suggests an openness to integrating advanced technologies into its solutions.

Leadership Team

The leadership team at United Animal Health includes:

Doug M. Webel: President & Chief Executive Officer.

Stephen D. Biddle: Vice President.

Michael King: Managing Director, Microbial Discovery Group.

Dave Crim: Position not specified.

Leadership Changes

Specific details regarding recent significant changes or appointments within the company's leadership are not publicly available.

Competitor Profile

Market Insights and Dynamics

The animal health industry is highly competitive, with leading companies such as Zoetis, MSD Animal Health, Elanco, Boehringer Ingelheim, and Ceva Santé Animale collectively holding a majority of the market share. Competition is driven by innovation in biologics, precision medicines, digital health solutions, and vaccines, with firms continuously investing in research to address emerging diseases, improve animal welfare, and enhance productivity.

Competitor Analysis

United Animal Health faces competition from various established players and emerging companies in the market. Notable competitors include:

Grubbly Farms: Focuses on harvesting larvae for fertilizer production and animal feed.

Nutrition Technologies: Provides insect-based products for agriculture and livestock.

Beta Hatch: An integrated business for cultivation and processing of mealworm insects to supply poultry & aquaculture feed and organic fertilizer.

Loopworm: Develops insect-based proteins and biomaterials for multiple industries.

BioFlyTech: Produces and supplies insect-based animal feeds.

Strategic Collaborations and Partnerships

United Animal Health has established various collaborations and partnerships to strengthen its market position and innovation capacity. Notably, the company co-founded the Microbial Discovery Group in 2007, expanding its capabilities in microbial discovery and fermentation science. Additionally, United Animal Health co-founded Pivotal Ingredients in 2020, further enhancing its research and development initiatives.

Operational Insights

United Animal Health's strategic considerations include maintaining close relationships with customers to understand their needs, leveraging its research and development capabilities to drive product innovation, and expanding its presence in key markets to strengthen its position in the supply chain.

Strategic Opportunities and Future Directions

The company's strategic roadmap focuses on advancing biological technologies to meet the growing global demand for animal protein. By applying scientific discovery to practical production systems, United Animal Health aims to support the future of animal agriculture through innovation and collaboration with producers and industry partners.